ra 642 has been researched along with ascorbic acid in 1 studies
| Studies (ra 642) | Trials (ra 642) | Recent Studies (post-2010) (ra 642) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | ra 642 (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrasco, T; de la Cruz, JP; Ortega, G; Sanchez de la Cuesta, F | 1 |
1 other study(ies) available for ra 642 and ascorbic acid
| Article | Year |
|---|---|
Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes.
Topics: Animals; Ascorbic Acid; Cardiotonic Agents; Cell Membrane; Dipyridamole; Ferrous Compounds; Humans; Kinetics; Lipid Peroxidation; Liver; Malondialdehyde; Mopidamol; Pyrimidines; Rats; Species Specificity; Vitamin E | 1992 |